The standard nevus of Ota treatment is the Q-switched Nd:YAG laser at 1064nm, delivered over multiple sessions spaced weeks to months apart. Because nevus of Ota is a lesion of dermal melanocytes sitting deep in the skin, a nanosecond 1064nm pulse is used to reach that depth, fragment the pigment, and let the body clear it gradually. This guide covers why the laser works, practical settings, how many sessions to expect, and aftercare.
Last reviewed: June 2026.
What is nevus of Ota, and why does it need a laser?
Nevus of Ota is a benign, blue-grey to brown pigmentation, usually on one side of the face along the ophthalmic and maxillary branches of the trigeminal nerve (around the eye, temple, cheek, and forehead). It is a dermal melanocytosis: the pigment sits in melanocytes scattered through the dermis rather than in the surface epidermis. The HONKON dermatology training atlas in our knowledge base states plainly that nevus of Ota "is caused by abnormally increased dermal melanocyte which contains a large number of melanin," which is exactly why topical creams and superficial peels do not work on it.
According to DermNet, the condition is present at birth in roughly half of cases and appears more often in females, and first-line treatment is usually a 1064nm Q-switched Nd:YAG, alexandrite, or Q-switched ruby laser. Because the target is deep, a device that couples the right wavelength with a very short pulse is essential. Our internal clinical archive reaches the same conclusion: "Because Nevus of Ota is a dermal melanocytic lesion, so Q-Switched ND:YAG laser is the first choice."
Why 1064nm Q-switched Nd:YAG specifically?
Two properties matter: depth and speed. Longer wavelengths penetrate deeper into skin, and 1064nm reaches the mid-to-deep dermis where nevus of Ota melanocytes live, whereas the frequency-doubled 532nm output is absorbed more superficially and is better suited to epidermal spots. The Q-switch itself compresses the laser output into nanosecond pulses. That extreme brevity concentrates energy on the pigment fast enough to shatter it mechanically before heat spreads to surrounding tissue, the principle known as selective photothermolysis.
The mechanism is photoacoustic, not thermal burning. The 1064QCH operator manual in our knowledge base describes it well: the laser "in ultra-short nanosecond the light penetrates the tissue and is absorbed by the pigments and result in an instantaneous blast. The pigment particles are shattered into fragments" that are then engulfed by phagocytes and removed through the lymphatic system. That clearance takes time, which is the fundamental reason a single pass cannot remove the lesion and repeated sessions are required. You can read more on device choices in our guide to the Q-switched Nd:YAG laser platform and a deeper comparison in EO Q-switched vs standard Nd:YAG.
Q-switched laser settings for nevus of Ota
There is no single "correct" number, and settings must be titrated to the individual patient and skin type at the start of every session. The general approach is to select 1064nm, use a relatively small spot, and start at a conservative fluence, then raise it gradually until you reach the clinical endpoint. In their prospective study of 50 patients, Kar and Gupta (2011, Indian Journal of Dermatology, Venereology and Leprology) used a 3mm spot at 1064nm and built fluence up from roughly 2.5 to 3 J/cm2 toward a maximum near 8.5 J/cm2 across sessions.
| Parameter | Typical practitioner approach | Notes |
|---|---|---|
| Wavelength | 1064nm | Reaches deep dermal pigment; 532nm is reserved for superficial pigment |
| Pulse duration | Nanosecond (single-digit ns) | Photoacoustic fragmentation; HONKON MV10/MV11 deliver a 6-8ns pulse |
| Spot size | Small (Kar and Gupta used 3mm) | Smaller spot raises fluence for a given energy |
| Fluence | Start low, titrate up over sessions | Kar and Gupta ranged about 2.5-8.5 J/cm2; adjust to endpoint and skin type |
| Repetition rate | Low | 1064QCH is adjustable 1-10Hz; slow, controlled passes |
| Clinical endpoint | Immediate greyish-white frosting | Avoid pinpoint bleeding, blistering, or tissue splatter |
Note on energy: our internal clinical guidance advises against treating nevus of Ota with single-pulse energy below 200mj, citing weak effect, more sessions, greater pain, and higher scarring risk. This is one reason clinics favour platforms with genuinely high single-pulse output rather than underpowered units.
What does a treatment session look like?
The 1064nm Q-switched Nd:YAG is a Class 4 laser, so procedure discipline matters as much as the settings. A typical session runs like this:
- Confirm the diagnosis and Fitzpatrick skin type, and photo-document the lesion under consistent lighting.
- Cleanse the area. The patient should avoid functional cosmetics or active topicals in the preceding weeks, as flagged in the device contraindications.
- Protect the eyes. Staff wear wavelength-rated goggles (the manual specifies 200-1080nm protection), and because lesions sit near the eye, use corneal or metal eye shields for the patient when treating close to the orbital rim.
- Test a small area, start at a low fluence, and raise it only until you reach the greyish-white frosting endpoint.
- Treat with a single, even pass. Avoid overlapping or stacking pulses on the same spot in one session.
- Cool the skin, apply a bland ointment, and give written aftercare and sun-protection instructions.
Full clinic-side workflow and lesion mapping are covered in our nevus of Ota treatment solution.
How many sessions, and how far apart?
Expect several sessions over one to two years, not a quick fix. Published series give a realistic range. Kar and Gupta (2011) treated patients at monthly intervals with an average of about five sessions over two years. Aurangabadkar (2008, Journal of Cutaneous and Aesthetic Surgery) reported an average of roughly six sessions at about two-month intervals over one year, with most patients achieving substantial clearing and the rest moderate improvement. Our own product knowledge base echoes the spacing rule from the earliest Q-switched work: "Multiple treatments, given about one month apart are necessary for best results."
Practical takeaways for setting patient expectations:
- Space sessions roughly one to two months apart to allow pigment clearance and skin recovery.
- Improvement is gradual and cumulative; visible change often builds over the first several sessions.
- Deeper, bilateral, or long-standing lesions tend to respond more slowly and may need more sessions.
- Some residual pigment or later recurrence is possible, so promise improvement, not a guaranteed permanent cure.
Aftercare and managing complications
Aftercare centres on protecting the healing skin and preventing post-inflammatory hyperpigmentation (PIH), which is the most common side effect. Give patients a simple checklist:
- Expect transient whitening, mild swelling, and possible pinpoint crusting for several days.
- Keep the area clean and apply a bland emollient or the prescribed ointment; do not pick or scrub any crusts.
- Use strict broad-spectrum sun protection between sessions to reduce the risk of PIH.
- Avoid active topicals, harsh exfoliation, and heat on the treated area until healed.
- Report unusual pain, spreading redness, or signs of infection promptly.
On complications, Aurangabadkar (2008) reported that transient PIH affected only a minority of patients and resolved within about two months, with no scarring seen in that series. Our clinical atlas is consistent: with experienced operators and suitable equipment, complications are rare, though inflammatory hyperpigmentation and, occasionally, scarring can occur. Standard contraindications from the device manuals include pregnancy, active herpes or infection in the treatment field, malignant lesions, existing scars in the area, and recent local surgery.
Recommended equipment for nevus of Ota
For dermal pigment you want a Q-switched Nd:YAG platform with a strong 1064nm single pulse, an articulated arm for stable delivery, and an adjustable spot. Pmise's Q-switched range fits this profile:
- 1064QCH: a full-size Q-switched Nd:YAG with articulated-arm delivery, dual 1064nm and 532nm output, adjustable spot and 1-10Hz repetition rate, designed for pigment and tattoo work including dermal lesions.
- MV9: a Q-switched Nd:YAG pigment system in the same family, suited to clinics wanting 1064/532nm dual-wavelength pigment treatment.
- MV8: a compact option for clinics building out a pigment and rejuvenation service line.
If you are weighing pulse technologies, our comparison of long-pulse vs Q-switched Nd:YAG explains why the nanosecond Q-switch, not a long pulse, is the tool for pigment. Whichever unit you choose, the deciding factors are real single-pulse energy at 1064nm, beam stability, and reliable spot control.
Frequently Asked Questions
How many Q-switched laser sessions does nevus of Ota need?
Plan for several sessions spread over one to two years. Published series report averages of roughly five sessions at monthly intervals (Kar and Gupta, 2011) and about six sessions at two-month intervals (Aurangabadkar, 2008). Deeper or bilateral lesions may need more. Improvement is gradual, so counsel patients to expect steady clearing rather than a single dramatic result.
Why 1064nm instead of 532nm for nevus of Ota?
Nevus of Ota pigment sits deep in the dermis, and the longer 1064nm wavelength penetrates far enough to reach it. The 532nm output is absorbed more superficially, making it better for epidermal spots and freckles than for dermal melanocytosis. Most protocols therefore use 1064nm as the primary wavelength for nevus of Ota.
Does nevus of Ota laser treatment hurt, and what is the downtime?
Patients typically feel a rapid snapping or stinging sensation, often managed with topical anaesthetic and cooling. Immediately after, the skin shows a greyish-white frost, then mild swelling and sometimes pinpoint crusting for a few days. Downtime is usually short, but strict sun protection between sessions is important to limit post-inflammatory pigmentation.
Can the laser remove nevus of Ota completely?
Many patients achieve major clearing, and some near-complete results, but outcomes vary and residual pigment or later recurrence is possible. It is safer to describe the goal as substantial, lasting improvement rather than a guaranteed permanent cure. Realistic counselling, adequate sessions, and diligent aftercare give the best chance of a strong result.
Written by the Pmise Technical Team. Pmise manufactures laser and light-based aesthetic systems for clinics and distributors worldwide; this article draws on device operating manuals and clinical training references, with treatment data cited from peer-reviewed dermatology literature.
